Protara Therapeutics, Inc. (TARA)

Protara Therapeutics Statistics

Total Valuation

TARA has a market cap or net worth of $198.31 million. The enterprise value is $56.65 million.

Market Cap	198.31M
Enterprise Value	56.65M

Important Dates

The next estimated earnings date is Monday, November 3, 2025, before market open.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	n/a

Share Statistics

TARA has 38.58 million shares outstanding. The number of shares has increased by 139.68% in one year.

Current Share Class	38.58M
Shares Outstanding	38.58M
Shares Change (YoY)	+139.68%
Shares Change (QoQ)	+3.84%
Owned by Insiders (%)	2.51%
Owned by Institutions (%)	74.05%
Float	35.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.37
P/TBV Ratio	1.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.82, with a Debt / Equity ratio of 0.03.

Current Ratio	12.82
Quick Ratio	12.61
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -43.02% and return on invested capital (ROIC) is -29.21%.

Return on Equity (ROE)	-43.02%
Return on Assets (ROA)	-27.72%
Return on Invested Capital (ROIC)	-29.21%
Return on Capital Employed (ROCE)	-38.97%
Revenue Per Employee	n/a
Profits Per Employee	-$1.54M
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +119.66% in the last 52 weeks. The beta is 1.53, so TARA's price volatility has been higher than the market average.

Beta (5Y)	1.53
52-Week Price Change	+119.66%
50-Day Moving Average	4.17
200-Day Moving Average	3.79
Relative Strength Index (RSI)	56.94
Average Volume (20 Days)	502,662

Short Selling Information

The latest short interest is 2.86 million, so 7.40% of the outstanding shares have been sold short.

Short Interest	2.86M
Short Previous Month	2.46M
Short % of Shares Out	7.40%
Short % of Float	8.05%
Short Ratio (days to cover)	3.64

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-57.35M
Pretax Income	-50.86M
Net Income	-50.86M
EBITDA	-57.01M
EBIT	-57.35M
Earnings Per Share (EPS)	-$1.53

Balance Sheet

The company has $122.22 million in cash and $3.95 million in debt, giving a net cash position of $141.66 million or $3.67 per share.

Cash & Cash Equivalents	122.22M
Total Debt	3.95M
Net Cash	141.66M
Net Cash Per Share	$3.67
Equity (Book Value)	144.42M
Book Value Per Share	3.74
Working Capital	115.33M

Cash Flow

In the last 12 months, operating cash flow was -$44.71 million and capital expenditures -$74,000, giving a free cash flow of -$44.78 million.

Operating Cash Flow	-44.71M
Capital Expenditures	-74,000
Free Cash Flow	-44.78M
FCF Per Share	-$1.16

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TARA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-139.68%
Shareholder Yield	-139.68%
Earnings Yield	-25.65%
FCF Yield	-22.58%

Analyst Forecast

The average price target for TARA is $19.80, which is 285.21% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.80
Price Target Difference	285.21%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-35.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1